Most Viewed Articles
Articles | Fulltext downloads | PDF downloads | Total downloads |
---|---|---|---|
EditorialIndian Journal of Skin Allergy – Embracing new horizonsFull text | PDFYear: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_39_2023 |
1,060 | 85,310 | 86,370 |
Review ArticleReactive and proactive treatment in atopic dermatitis: Long-term disease controlFull text | PDFYear: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_31_2023 |
2,090 | 82,581 | 84,671 |
CommentaryStatus of research and publication in IndiaFull text | PDFYear: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_29_2023 |
1,724 | 72,974 | 74,698 |
EditorialEczema and skin allergy-focus on researchFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_29_2024 |
986 | 60,045 | 61,031 |
Case ReportHair depigmentation in a patient treated with pazopanib: A case report and a comprehensive analysisFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_52_2023 |
2,247 | 43,416 | 45,663 |
Original ArticleEfficacy and safety of crisaborole ointment in pediatric atopic dermatitis: A 4-week open-label studyFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_45_2023 |
1,733 | 39,196 | 40,929 |
Letter to EditorMethotrexate in refractory chronic urticariaFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_15_2024 |
1,490 | 38,055 | 39,545 |
Case ReportAmbroxol-induced leukocytoclastic vasculitis: A case report and literature reviewFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_37_2023 |
1,595 | 36,460 | 38,055 |
Review ArticleCutaneous adverse drug reactions in children with a focus on hypersensitivity to systemic drugs: A narrative reviewFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_14_2024 |
774 | 34,689 | 35,463 |
Original ArticleComorbidities in patients with chronic urticaria: A cross sectional study from an Urticaria Center of Reference and ExcellenceFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_26_2023 |
1,762 | 23,671 | 25,433 |
SymposiumInvestigations and treatment of photodermatosesFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_6_2024 |
990 | 20,280 | 21,270 |
Case ReportA novel pitch against the itchFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_13_2024 |
1,739 | 18,079 | 19,818 |
Case ReportPembrolizumab-induced resolving papulosquamous eruption: An enigmatic presentation in a patient with renal cell carcinomaFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_3_2024 |
1,416 | 17,842 | 19,258 |
Review ArticlePigmented contact dermatitis: An updated reviewFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_44_2023 |
2,879 | 13,103 | 15,982 |
ImageGiant fixed drug eruptionFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_47_2023 |
1,878 | 13,481 | 15,359 |
Letter to EditorPost-herpetic neuralgia-associated patchy hair loss closely mimicking trichotillomaniaFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_19_2024 |
1,236 | 12,726 | 13,962 |
Letter to EditorDasatinib-induced hand foot syndrome followed by bosutinib-induced photoallergic contact dermatitis in a patient of chronic myeloid leukemia: A rare co-occurrenceFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_1_2024 |
1,190 | 10,633 | 11,823 |
Letter to EditorHomemade lip injection for cosmetic purpose: A case reportFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_42_2023 |
986 | 10,569 | 11,555 |
SymposiumPhototoxicity and photoallergy – A brief review on pathogenesis, recent advances, and approach to a patient with photosensitivityFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_9_2024 |
1,211 | 9,781 | 10,992 |
SymposiumCutaneous photobiologyFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_11_2024 |
1,737 | 8,270 | 10,007 |
Letter to EditorCutaneous vasculitis as the sole clinical feature of primary Sjögren’s syndromeFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_48_2023 |
1,850 | 8,121 | 9,971 |
Original ArticleStudy of effectiveness of methotrexate oral pulse in refractory chronic urticariaFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_28_2023 |
1,720 | 7,917 | 9,637 |
Original ArticleThe effectiveness of bilastine and fexofenadine updosing in the management of chronic spontaneous urticariaFull text | PDFYear: 2022, Volume: 1, Issue: 2, July-December DOI: 10.25259/IJSA_3_2021 |
8,124 | 1,213 | 9,337 |
Resident’s CornerAllergic reactions to radiocontrast media–A brief overviewFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_4_2024 |
1,175 | 8,110 | 9,285 |
Letter to EditorHot car seat thermal burn: A must sought for differential diagnosis in summersFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_31_2024 |
884 | 8,177 | 9,061 |
Letter to EditorHeat urticaria – Characterizing the population from an urticaria center of reference and excellence (UCARE)Full text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_51_2023 |
2,030 | 6,918 | 8,948 |
Original ArticleImpact of atopic dermatitis on quality of life in children and their families: A tertiary care hospital-based study from Northern IndiaFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_5_2024 |
1,901 | 6,643 | 8,544 |
SymposiumPolymorphous light eruptionsFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_8_2024 |
968 | 7,574 | 8,542 |
Case ReportSubacute cutaneous lupus erythematosus in a patient of pancreatic cancer secondary to novel albumin-bound paclitaxel chemotherapyFull text | PDFYear: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_25_2023 |
1,192 | 7,099 | 8,291 |
Review ArticleA review of comorbidities in atopic dermatitisFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_37_2024 |
1,501 | 6,617 | 8,118 |
CommentaryFellowship and mentorship opportunities in allergic skin disorders for Indian dermatologistsFull text | PDFYear: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_30_2023 |
1,280 | 6,835 | 8,115 |
Original ArticleAtopic dermatitis in teenagers and adults: Clinical features of a tertiary referral hospitalFull text | PDFYear: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_21_2022 |
1,274 | 6,715 | 7,989 |
Author’s replyPembrolizumab-induced resolving papulosquamous eruption: An enigmatic presentation in a patient with renal cell carcinomaFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_41_2024 |
1,043 | 6,502 | 7,545 |
Letter to EditorTeledermatology trends during two waves of the COVID-19 pandemic – Experience from western RajasthanFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_21_2024 |
1,000 | 6,464 | 7,464 |
Case ReportPenile angioedema in a child: A nightmare to parents!Full text | PDFYear: 2022, Volume: 1, Issue: 1, January-June DOI: 10.25259/IJSA_5_2021 |
6,611 | 846 | 7,457 |
SymposiumChronic actinic dermatitisFull text | PDFYear: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_10_2024 |
939 | 6,086 | 7,025 |
Original ArticlePatch testing with Indian standard series of 20 allergens in 125 patients of chronic dermatitis and dermatosesFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_16_2024 |
1,700 | 5,185 | 6,885 |
Review ArticleStem-cell therapy in dermatology – Challenges and opportunitiesFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_50_2023 |
1,628 | 5,195 | 6,823 |
Letter to EditorAre dermatologists a well-informed audience for artificial intelligence? A knowledge, attitude, and practice surveyFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_20_2024 |
1,146 | 4,264 | 5,410 |
Review ArticleJAK inhibitors in dermatologyFull text | PDFYear: 2023, Volume: 2, Issue: 1, January-June DOI: 10.25259/IJSA_7_2021 |
4,227 | 999 | 5,226 |
Case ReportA rare case of diffuse penile phytocontact dermatitis caused by common greenbrierFull text | PDFYear: 2023, Volume: 2, Issue: 1, January-June DOI: 10.25259/IJSA_22_2022 |
2,646 | 1,668 | 4,314 |
Review ArticleChronic inducible urticaria: Clinical presentation, diagnosis, and managementFull text | PDFYear: 2022, Volume: 1, Issue: 1, January-June DOI: 10.25259/IJSA_12_2021 |
2,824 | 705 | 3,529 |
Letter to EditorSymmetrical drug-related intertriginous and flexural exanthema without baboon syndrome due to paracetamol: An uncommon side effect of a common drug: A case report and a review of literatureFull text | PDFYear: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_30_2024 |
710 | 2,783 | 3,493 |
Case SeriesHand eczema associated with frequent hand washing and use of hand sanitizer during COVID-19 pandemic: A case seriesFull text | PDFYear: 2022, Volume: 1, Issue: 2, July-December DOI: 10.25259/IJSA_11_2021 |
2,433 | 930 | 3,363 |
Letter to EditorInducible urticaria or skin lesions induced by Nd: YAG laser?Full text | PDFDOI: 10.25259/IJSA_41_2023 |
975 | 2,370 | 3,345 |
Letter to EditorExosome therapy in atopic dermatitis – A way to look forwardFull text | PDFYear: 2023, Volume: 2, Issue: 1, January-June DOI: 10.25259/IJSA_26_2022 |
1,641 | 1,666 | 3,307 |
Review ArticleDigital object identifier: What it is and why it matters?Full text | PDFYear: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_20_2023 |
2,615 | 541 | 3,156 |
Review ArticleLigelizumab: A novel molecule in the management of chronic spontaneous urticariaFull text | PDFYear: 2023, Volume: 2, Issue: 1, January-June DOI: 10.25259/IJSA_8_2023 |
1,606 | 1,531 | 3,137 |
Review ArticleBiomarkers of chronic spontaneous urticariaFull text | PDFYear: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_14_2023 |
2,421 | 708 | 3,129 |
ObituaryObituary: Dr. A. K. Bajaj (1945–2021)Full text | PDFYear: 2022, Volume: 1, Issue: 1, January-June DOI: 10.25259/IJSA_1_2022 |
2,452 | 537 | 2,989 |